Institutionelle bei Idec Pharmaceuticals

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Citigroup Inc. 15,183,879 $523,236,470
Morgan Stanley 7,994,755 $275,499,257
BB Biotech Ag 4,682,000 $161,341,720
Putnam Investment Management, Inc. 4,370,071 $150,592,646
American Express Financial Corp 4,268,698 $147,099,333
Oppenheimerfunds, Inc. 4,048,265 $139,503,211
FMR Corporation (Fidelity Management & Research Corp) 18,819,494 $648,519,763
Allianz Dresdner Asset Management Of America, Inc. 3,003,298 $103,493,649
Barclays Bank Plc 2,831,648 $97,578,590
Price (T.Rowe) Associates 2,795,204 $96,322,729

Topliste der investierten Fonds
Smith Barney Aggressive Growth Fund Inc. 4,800,000 $165,408,000
Fidelity Aggressive Growth Fund 4,717,250 $162,556,435
Fidelity Select Portfolios - Biotechnology 3,371,140 $116,169,484
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 3,192,680 $110,019,752
Fidelity Otc Portfolio 1,570,000 $54,102,200
Growth Fund of America Inc 1,558,500 $53,705,910
Vanguard Specialized-Health Care Fund 1,560,000 $53,757,600
Morgan Stanley American Opportunities Fd 1,389,410 $47,879,068
Fidelity Mid-Cap Stock Fund 1,383,420 $47,672,653
Merrill Lynch Fundamental Growth Fund 1,320,000 $45,487,200